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Abstract 
 
The prevalence of lower urinary tract (LUT) symptoms increases with age but the aetiology is unknown.  
This article aims to identify research directions that clarify the basis of this association.  The initial 
question is whether biological age is the variable of interest or a time-dependent accumulation of factors 
that impact on LUT function at rates that differ between individuals.  In particular, the accumulation of 
conditions or agents due to inflammatory states or tissue ischaemia are important.  Much of the above 
has been concerned with changes to bladder function and morphology.  However, the outflow tract 
function is also affected, in particular changes to the function of external sphincter skeletal muscle and 
associated sacral motor nerve control.  Nocturia is a cardinal symptom of LUT dysfunction and is more 
prevalent with ageing.   Urine production is determined by diurnal changes to the production of certain 
hormones as well as arterial blood pressure and such diurnal rhythms are blunted in subjects with 
nocturia, but the causal links remain to be elucidated.  Changes to the central nervous control of LUT 
function with age are also increasingly recognized, whether in mid-brain/brainstem regions that 
directly affect LUT function or in higher centres that determine psycho-social and emotional factors 
impinging on the LUT.  In particular, the linkage between increasing white matter hyperintensities and 
LUT dysfunction during ageing is recognized but not understood.  Overall, a more rational approach is 
being developed to link LUT dysfunction with factors that accumulate with age, however, the precise 
causal pathways remain to be characterized. 
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An increased prevalence of LUT disorders is associated with age, but questions remain unresolved that 
surround this simple statement.  For example, does LUT dysfunction develop as a natural ageing process 
or is it dependent on other factors that have a cumulative effect on the LUT until a threshold breakdown 
occurs?  Furthermore, what regions of the LUT are most affected that eventually lead to dysfunction: the 
contracting detrusor, the outflow tract, sensations during bladder filling, or central and peripheral 
control of LUT function?  Nearly all these questions remain unanswered and it is the purpose of this 
article to introduce specific areas of interest and highlight research questions that may shed light on 
why LUT dysfunction occurs more as the arrow of time progresses.  
Ageing as an entity.  Although the passage of time is associated with increased LUT dysfunction, no causal 
relationship has been demonstrated and is equally possible to assert that as a person lives longer there 
is a greater likelihood they will acquire conditions that may impact on LUT function. Thus, the process 
of age-related changes based on chronological age alone is unlikely to develop our understanding of age-
associated LUT dysfunction.  
Longitudinal studies of sufficient magnitude and length are very difficult to carry out; therefore to truly 
ascribe physiological changes to the passage of time we need to agree upon a description of 
physiological or perhaps pathophysiological age to conduct robust cross-sectional studies. It is likely 
that a mere absence of symptoms or overt major systems disease will be insufficient. 
Biological systems have a significant reserve to ensure adequate function over a lifespan despite 
external stresses – a property called compensation.  Failure (decompensation) occurs if the biological 
reserve collapses due to excessive stresses or if the compensatory alterations induce their own 
dysfunction.  This is captured in a redundancy model of ageing whereby systems are described as 
“blocks” which do not age per se, but fail for various reasons and an ageing effect occurs as redundancy 
is exhausted [1].  The rate of failure of “blocks” within a system varies and also depends on the number 
of remaining “blocks”, some of which may be critical for survival.  This latter dependency may indicate 
an intrinsic phenomenon affecting the whole organism leading to failure of the weakest link or critical 
system [2]. 
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Two examples of cumulative changes that can exert long-term impact on the urinary tract are 
inflammaging and gradual accumulating ischaemia in the LUT itself or its nervous control.  
Inflammaging is characterised by upregulation of the inflammatory response that occurs with advancing 
age [3] due to cumulative lifetime exposures to antigenic loads from clinical and subclinical infections 
as well as non-infective antigens. The consequent inflammatory response elicits the release of additional 
cytokines resulting in a pro-inflammatory state. Irreversible cellular and molecular damage, that is not 
clinically evident, therefore slowly accumulates over decades.  Equally, perfusion impairment as a result 
of conditions such as atherosclerosis affects both voiding and storage LUT function independent of age 
[4], but the critical sites of ischaemic damage to the LUT and its regulators have not yet been identified. 
In addition to the accumulation of pathological impacts, the elderly also tend to be exposed to more 
general pressures that can impact on LUT function.   Two examples again illustrate the range of these 
confounding factors.  The elderly tend to take an increasing number of different medications for other 
conditions.  However, it is difficult to assess how this spectrum of polypharmacy affects LUT function 
but must always be considered as a complicating factor.  Secondly, fluid intake in the elderly can be very 
different from the general population, especially those in care homes where intake can be very low.  
Prolonged dehydration leading to renal failure can diminish the ability of the kidneys to appropriately 
concentrate urine and in some generate polyuria, whilst in others oliguria will impact on normal bladder 
wall filling sensations. 
Changes to structure and function of the bladder with ageing: human and animal studies.  Several 
variables have been formulated for use in human studies that measure detrusor contractile strength, 
when voiding, including the bladder contractility index (BCI) and the Watts Factor [5].  Cohort studies 
show a small decline of BCI with age (6) and calculation of the maximum detrusor-Watts Factor during 
voiding shows age-dependent reductions of about 15% and 35%, in men and women respectively, 
between 50 to 80 years of age (P Rosier, ICS-2015, abstract 267).  It remains to be ascertained how these 
clinical indices are interpreted in terms of physiological function associated with LUT contractile 
function. 
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To gain insight into particular pathological changes associated with LUT dysfunction, ‘aged’ animals are 
used in comparison to younger ones. However, most laboratory animals have much shorter life-spans 
than humans and changes occurring in animal models, throughout their lifespan, may not mirror those 
in humans.  One determination of an ageing animal is the appearance of biomarkers associated with 
senescence, as may occur in humans over 65 years, and using this criterion, rats and mice older than 18-
24 months and guinea-pigs older than 30 months would be appropriate [7]. However, many reports 
from ‘aged’ models use younger animals and so some of the resulting data must be interpreted with 
caution.  
With respect to human tissue, increasing age and bladder outflow obstruction (BOO) is associated with 
an increase of the collagen:muscle ratio in tissue biopsies from men [8] and mirrored in a decline of in 
vitro contractility [9].  However, the greater fibrosis with BOO is associated with greater detrusor 
voiding pressure indicating bladder wall hypertrophy [10].  These changes are reflected in some, but 
not all, animal equivalents [7,11].  In addition, the bladder wall contains various cell types such as 
epithelial cells, nervous and vascular supplies, connective tissue, interstitial cells and immune system 
cells. Interaction between these different cell types is complex and regulation of bladder function 
depends upon integration of their individual activities. Investigation of the interactions between these 
cells types, as a function of age, should provide important insights into LUT dysfunction. The passage of 
time has other, profound effects, such as denervation of afferent and efferent nerves to bladder tissues 
[7,11].  This may be countermanded by increased release of neuroactivators from the mucosa during 
external stresses [12,13].  Thus far, it has not been possible to use animal models to determine if changes 
occurring to LUT function in ageing humans are part of a senescence process or the accumulation of 
pathological burdens that gradually degrade function. 
Impact of ischemia on the aging process of the bladder.  Ageing is associated with impaired blood vessel 
function, characterised by endothelial dysfunction mediated largely by NO insufficiency through 
oxidative stress and chronic low-grade inflammation [14].  Arterial endothelial dysfunction is the 
primary antecedent for atherosclerotic diseases, which can result in bladder ischaemia and the 
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development of LUTS [15].  Elderly patients with LUTS do have a significantly greater bladder blood 
flow resistance index, measured with transrectal ultrasound colour Doppler, in comparison to younger 
(40 yrs) people with low symptom scores [16].  Pelvic arterial insufficiency can result in the 
development of detrusor overactivity and eventually detrusor underactivity [17].  One mechanism is 
potentially through bladder ischaemia and bladder wall hypoxia [18], with resultant oxidative stress, 
increased muscarinic receptor activity, ultrastructural damage and neurodegeneration [19].    
It would be desirable to treat not only LUT symptoms (LUTS) induced by chronic ischemia, but also the 
progression of morphological changes that occur in detrusor muscle and other structures within the 
bladder wall.  Several drug types have been proposed as having potential to influence some of these 
changes.  The α1-adrenoceptor blocker silodosin, the β3-AR agonist mirabegron, and the free radical 
scavenger melatonin all had a protective effect on both urodynamic parameters and in vitro functional 
and morphological bladder changes even though they do not prevent development of neointimal 
hyperplasia and bladder ischaemia in animal models: the PDE5 inhibitor tadalafil did not demonstrate 
any positive effect on urodynamic parameters [20]. This variety of effective agents suggests a 
multifactorial pathogenesis of bladder dysfunction induced by chronic ischaemia.  As several of the 
agents are used clinically to relieve LUTS these results have translational value, and should be used to 
design clinical studies to demonstrate whether progression of ischemia-related functional and 
morphological bladder changes can be limited. 
The bladder outflow tract with ageing. The external urethral sphincter (EUS) contains a crucial ring of 
striated muscle, the rhabdosphincter. With increasing bladder filling, tonic EUS contractions 
progressively increase, but at the initiation of voluntary voiding both the bladder neck circumferential 
muscle fibers and the EUS relax as the bladder dome contracts.   Somatic motor neurons from Onuf’s 
nucleus in the sacral spinal cord innervate, via the pudendal nerve, and excite muscle fibres of the EUS 
via acetylcholine acting on nicotinic receptors.  Glutamate is the main excitatory neurotransmitter on 
these motor neurons, which in turn is augmented by serotonin and noradrenaline, demonstrating a 
complex control of rhabdosphincter function by Onuf’s nucleus [21,22].  Stress urinary incontinence 
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(SUI) is prevalent in the older population and importantly is due to failure of the EUS mechanism.  There 
remains little information about the pathological changes that accompany development of SUI but may 
include: a loss of muscle fibre numbers; reduced contractile performance; denervation of motor nerves; 
failure of neurotransmission at the motor end plate; or changes to the spinal control system. Pelvic nerve 
neuropathy might play a role in women with SUI [23] and animal models of pudendal nerve transection 
showed atrophy of the EUS striated muscle [24].  Intraurethral sonography also shows a decrease of 
sphincter muscle thickness as a function of patient age in women with SUI [25].  However, a great deal 
remains to be determined about the muscle mechanics of EUS striated muscle, how contractile function 
is regulated via Onuf’s nucleus, and what changes of function occur that are associated with SUI and its 
relation to increasing age of the patient. 
Nocturia, an age-determined phenomenon?  The prevalence of nocturia, awakening at least once a night 
to void and followed by sleep, increases with age and two or more episodes is associated with increased 
risk of falls and fractures, cardiovascular events and poor sleep quality [26].  A frequency-volume chart 
is useful to determine whether nocturia is due to a reduced bladder capacity, nocturnal polyuria, 24-
hour polyuria or a combination [27].  In addition, patients with nocturnal polyuria can be classified as 
those with a raised free water or sodium clearance at night.  Sleep, bladder capacity and urine 
production are subject to circadian rhythms that diminish with increasing age [28, 29] and are driven 
by cyclical release of hormones such as vasopressin (ADH), angiotensin, aldosterone and melatonin 
[29,30].  These hormones not only regulate renal sodium and water handling but can also directly or 
indirectly influence arterial blood pressure (ABP).  The association between ABP and renal function, 
especially in relation to nocturnal urine volumes [31], has several consequences.  During sleep ABP falls 
by 10-20%, in part due to physical inactivity (of interest the extent of this diurnal variation may be an 
independent predictor of cardiovascular dysfunction).   The diurnal variation is also less in subjects who 
exhibit nocturia [32].  Indeed, the association between arterial blood pressure and nocturnal urine 
volumes may explain why subjects with essential hypertension experience a greater incidence of 
nocturia and increased night-time sodium excretion, compared to the normal population [29].  
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However, the precise causal linkages between cardiovascular function and nocturia remain to be 
evaluated. 
Contribution from the brain and other external factors to dysfunction of bladder structure, function and 
voiding.   Increasing evidence suggests that, with ageing, central nervous control of the LUT is affected. 
Normal voiding engages a spino-midbrain-spinal neural loop.  Afferent information on bladder status is 
relayed to the midbrain periaqueductal grey matter (PAG) and thereafter to the pontine micturition 
centre (PMC), the source of spinally-projecting neurons that control motor outflows to the detrusor and 
sphincter muscles.  During bladder filling, tonic inhibition of the voiding circuit by GABA is imposed at 
a midbrain level and results in a low level of PAG activation [33].  However, once the voiding threshold 
is reached, the GABA tone is lifted with a stepped increase of PAG activation and recruitment of the PMC 
as the circuitry switches to voiding mode [34].  In humans and other socialised species voiding occurs 
only when the individual judges it to be appropriate, even when the bladder is full.  Forebrain structures, 
probably the prefrontal cortex, must exert control over the basic pontine and sacral voiding circuits [35].  
fMRI imaging during bladder filling shows that at low volumes, when there is little conscious bladder 
sensation, midbrain and parahippocampal regions are activated, but not cortical areas.  However, with 
a full bladder strong sensations ensue and the insula (thought to encode visceral sensation) and dorsal 
anterior cingulate/supplementary motor complex are activated, with some studies also showing de-
activation in the prefrontal cortex [36,37].  In ageing individuals, even those with normal LUT control, 
decreased responses to bladder filling are observed in the right insula, consistent with its role in 
perception of visceral sensation.  Failure to detect sensation until the bladder is extremely full may 
contribute to the development of urgency.  In elderly urgency incontinent individuals, activation in the 
anterior cingulate gyrus is stronger than normal which may represent a sign of urgency  [34,38].  
The presence in these brain regions of white-matter hyperintensities (WMH), which are  structural 
abnormalities which appear with ageing and may be linked to small vessel disease, are associated with 
LUT disorders. WMH in the right inferior frontal region and cingulate gyrus are associated with urinary 
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incontinence [39] and with detrusor overactivity when present in the right anterior thalamic radiation, 
which connects prefrontal regions with the thalamus and pontine voiding circuit.   
Bladder compliance increases with age in animal models [40], an effect which may contribute to the 
increased volume at which a first desire to void occurs in humans as they age [41]. The effect on 
compliance is more evident in vivo than with ex vivo bladders and suggests that the central nervous 
system mechanism regulating compliance [42], requires further evaluation.    
Psychosocial factors may also influence LUT function. Young adult mice when socially deprived 
developed non-voiding bladder contractions, similar to detrusor overactivity, and a decreased 
micturition interval in the short term (two weeks), but longer exposures increased both bladder 
capacity and micturition interval with resultant remodeling of the bladder wall [43].  One potential 
contributing factor may be altered release of corticotropin releasing factor (CRF), with more CRF 
immune-reactive neurons in the PMC after social stress. Ageing is associated with behavioural changes, 
including elevated anxiety or depression, narrowed social engagement, and cognitive impairment. The 
extent to which these factors contribute to age related LUT dysfunction is worthy of further 
investigation. 
 
The use of mathematical models to address interpration of changes to LUT function with ageing. The 
Valentini–Besson–Nelson (VBN) model [44] is a quantitative description of mechanistic phenomena 
that govern micturition including: detrusor contractility and viscoelasticity, urethral elasticity and 
sphincteric compression, hydrodynamics of turbulent incompressible fluids and abdominal straining. 
Each phenomenon can be separately studied: however when combined, as during voiding, they 
constitute an intricate set of variables that is best analysed with computer models such as VBN® 
software. Inputs include filling volume and catheter size (and gender); outputs are computed voiding 
curves, flow rate and detrusor pressure vs time. The status of the urethral sphincter is described by an 
“equivalent compression” VBN parameter U (units of pressure) and interpreted as a real compression 
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or change to its effective cross-section.  Detrusor force is characterized by the dimensionless VBN 
parameter k. 
An example of the use of the VBN model with urodynamic data is how detrusor contraction and 
sphincter function change with age in two populations of non-neurogenic women (20-90 years), with 
or without obstruction, and referred for evaluation of LUT disorders.  Modelling showed that in both 
groups k was constant with respect to age until an average menopausal time (50 years), and then 
decreased abruptly with further ageing (by 23% from 50 - 90 years).  With obstructed patients, k was 
greater and there was a significant correlation between the values of k and U in both groups at all ages.  
These observations are consistent with a deterioration of detrusor force and loss of striated sphincter 
function especially once the menopause has been achieved and is consistent with other studies [45,46].  
 
Research questions 
A large number of factors currently associated with ageing may also be linked to disordered LUT 
function.  However, in most cases a causal relationship has not been established and a number of key 
topics require investigation: 
1 Can we define better our concept of ‘ageing’, is it related merely to the passage of time or the 
expression of particular biomarkers?  Included in this is a need to collect better epidemiological data 
with regard to LUT dysfunction over a wide age range. 
2 Define the role of chronic bladder ischemia in the pathophysiology of human ageing-related LUT 
dysfunction. 
3 Develop better animal models of LUT functional changes related to ageing, rather than the middle-
aged normal animals used by many groups today?  How do we extrapolate findings from these models 
to the human condition with respect to LUT dysfunction? 
4 Characterise the physiological properties of rhabdosphincter skeletal muscle (human and animal 
tissues) and how these alter in well-defined pathological conditions, e.g. sarcopenia. 
5 Understand better the sacral control of pudendal nerve outputs related to effects of ageing and/or 
‘chronic load’ to the external urethral sphincter and or the pelvic muscles. 
 11 
6 Describe the age-dependence of circadian rhythms in hormones regulating renal sodium/water 
balance and blood pressure in the evaluation of patients with LUT dysfunction. 
7 Describe the effects of changes in bladder sensation, detrusor overactivity and nocturnal polyuria 
on LUT disorders.  Determine the effect of nocturia and nocturnal polyuria in patients treated for sleep 
disorders. 
8 Increase our understanding of how ageing affects specific areas of the brain that control the 
storage/voiding cycle. 
9 Explain the association of white matter hyperintensities, associated with older age and cognitive 
decline, with LUT dysfunction. 
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